Home > News > Nanotech Knocks on FDA's Door
October 16th, 2006
Nanotech Knocks on FDA's Door
Abstract:
“Thanks to the promise of nanotechnology, people will benefit from fantastic new prescription drugs and from better ways of getting existing pharmaceuticals into the body for more effective disease treatments. But new nano-enabled drugs and medical devices also place new burdens on an oversight agency that is already stretched extremely thin,” said Project on Emerging Nanotechnologies Director David Rejeski in a presentation today at the Food and Drug Administration’s first major public meeting on regulating products containing nanotechnology materials.
Source:
nanotechproject.org
Related News Press |
Preparing for Nano
Disruptive by Design: Nano Now February 1st, 2019
How nanoscience will improve our health and lives in the coming years: Targeted medicine deliveries and increased energy efficiency are just two of many ways October 26th, 2016
Searching for a nanotech self-organizing principle May 1st, 2016
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Food/Agriculture/Supplements
Silver nanoparticles: guaranteeing antimicrobial safe-tea November 17th, 2023
Night-time radiative warming using the atmosphere November 17th, 2023
DGIST and New Life Group launched a research project on "Functional beauty and health products using the latest nanotechnology" May 12th, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||